 Felbamate clinical trial complex partial seizures double-blind three-period cross-over study felbamate FBM dicarbamate Carter-Wallace patients complex partial seizures Patients carbamazepine CBZ study hospital entire trial period entry criteria seizures baseline period week single seizure CBZ Thirty subjects study randomization exacerbation hyponatremia CBZ therapy daily dosage mg/kg maximum mg FBM day patients study mild adverse experience trial FBM CBZ level confidence interval significant difference seizure frequency placebo FBM periods one-sided correction CBZ level FBM periods data strong antiseizure effect FBM